AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -25.0% | 245 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | +100.0% | 245 | 0.0% | 0.00% | – |
| Q1 2023 | $2 | 0.0% | 245 | 0.0% | 0.00% | – |
| Q4 2022 | $2 | -99.8% | 245 | +104.2% | 0.00% | – |
| Q3 2022 | $1,000 | – | 120 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 120 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q2 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 120 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -99.7% | 120 | -99.7% | 0.00% | -100.0% |
| Q1 2020 | $366,000 | +36500.0% | 46,100 | +20208.4% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 227 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -50.0% | 227 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 227 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |